Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potent and highly selective dual‐targeting monoamine oxidase‐B inhibitors: Fluorinated chalcones of morpholine versus imidazole
Bijo Mathew, Seung Cheol Baek, Della Grace Thomas Parambi, et al.
Archiv der Pharmazie (2019) Vol. 352, Iss. 4
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Morpholine as a privileged structure: A review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules
Angeliki P. Kourounakis, Dimitrios Xanthopoulos, Ariadni Tzara
Medicinal Research Reviews (2019) Vol. 40, Iss. 2, pp. 709-752
Closed Access | Times Cited: 202
A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer’s disease agents: A review
Shoaib Manzoor, Nasimul Hoda
European Journal of Medicinal Chemistry (2020) Vol. 206, pp. 112787-112787
Closed Access | Times Cited: 178
Antidepressant drugs as emerging contaminants: Occurrence in urban and non-urban waters and analytical methods for their detection
Carlos Castillo-Zacarías, Mario E. Barocio, Enrique Hidalgo-Vázquez, et al.
The Science of The Total Environment (2020) Vol. 757, pp. 143722-143722
Closed Access | Times Cited: 139
Synthetic strategies and medicinal chemistry perspectives of dual acting carbonic anhydrase modulators with monoamine oxidase and cholinesterase inhibitors
Sandeep Bindra, Ehab M. Mostafa, Mohamed A. Abdelgawad, et al.
RSC Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases
Bijo Mathew, Della Grace Thomas Parambi, Githa Elizabeth Mathew, et al.
Archiv der Pharmazie (2019) Vol. 352, Iss. 11
Closed Access | Times Cited: 119
Morpholine As a Scaffold in Medicinal Chemistry: An Update on Synthetic Strategies
Ariadni Tzara, Dimitrios Xanthopoulos, Angeliki P. Kourounakis
ChemMedChem (2020) Vol. 15, Iss. 5, pp. 392-403
Closed Access | Times Cited: 71
Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors
Paolo Guglielmi, Bijo Mathew, Daniela Secci, et al.
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112650-112650
Closed Access | Times Cited: 69
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 43
Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors
Della Grace Thomas Parambi, Jong‐Min Oh, Seung Cheol Baek, et al.
Bioorganic Chemistry (2019) Vol. 93, pp. 103335-103335
Closed Access | Times Cited: 60
Acetylcholinesterase and butyrylcholinesterase inhibitory activities of khellactone coumarin derivatives isolated from Peucedanum japonicum Thurnberg
Jeong Hyun Heo, Bo Hyun Eom, Hyung Won Ryu, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 50
Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors
Sachithra Thazhathuveedu Sudevan, Jong‐Min Oh, Mohamed A. Abdelgawad, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Probing the inhibition of MAO-B by chalcones: an integrated approach combining molecular docking, ADME analysis, MD simulation, and MM-PBSA calculations
Jisna Jose, Jibin K. Varughese, Mohammad K. Parvez, et al.
Journal of Molecular Modeling (2024) Vol. 30, Iss. 4
Closed Access | Times Cited: 5
Microwave-Assisted Synthesis of Morpholine-Based Chalcones as Reversible MAO-A Inhibitors in the Management of Mental Depression
Diksha Choudhary, Bhupinder Kumar, Balakumar Chandrasekaran, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 309-309
Open Access
Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?
Paolo Guglielmi, Simone Carradori, Alessandra Ammazzalorso, et al.
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 10, pp. 995-1035
Closed Access | Times Cited: 48
Perspective Design of Chalcones for the Management of CNS Disorders: A Mini-Review
Bijo Mathew, Della Grace Thomas Parambi, Vishnu Sankar Sivasankarapillai, et al.
CNS & Neurological Disorders - Drug Targets (2019) Vol. 18, Iss. 6, pp. 432-445
Closed Access | Times Cited: 46
Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors
Jong‐Min Oh, T. M. Rangarajan, Reeta Chaudhary, et al.
Molecules (2020) Vol. 25, Iss. 10, pp. 2356-2356
Open Access | Times Cited: 46
Calycosin and 8-O-methylretusin isolated from Maackia amurensis as potent and selective reversible inhibitors of human monoamine oxidase-B
Jong‐Min Oh, Hyun‐Jae Jang, Won Jun Kim, et al.
International Journal of Biological Macromolecules (2020) Vol. 151, pp. 441-448
Closed Access | Times Cited: 43
Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders
Bijo Mathew, Jong‐Min Oh, Roua S. Baty, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 29, pp. 38855-38866
Open Access | Times Cited: 38
Halogenated Coumarin–Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors
Nisha Abdul Rehuman, Jong‐Min Oh, Lekshmi R. Nath, et al.
ACS Omega (2021) Vol. 6, Iss. 42, pp. 28182-28193
Open Access | Times Cited: 37
Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations
Rani Sasidharan, Bo Hyun Eom, Jeong Hyun Heo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 188-197
Open Access | Times Cited: 33
An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects
Pratibha Sharma, Manjinder Singh
Life Sciences (2023) Vol. 320, pp. 121568-121568
Closed Access | Times Cited: 14
New Aspects of Monoamine Oxidase B Inhibitors: The Key Role of Halogens to Open the Golden Door
Bijo Mathew, Simone Carradori, Paolo Guglielmi, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 2, pp. 266-283
Closed Access | Times Cited: 37
Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
Vishal Payyalot Vishal, Jong‐Min Oh, Ahmed Khames, et al.
Pharmaceutics (2021) Vol. 13, Iss. 6, pp. 850-850
Open Access | Times Cited: 29
A structural approach to investigate halogen substituted MAO-B inhibitors using QSAR modeling, molecular dynamics, and conceptual DFT analysis
Naseer Maliyakkal, Iqrar Ahmad, Sunil Kumar, et al.
Journal of Saudi Chemical Society (2023) Vol. 27, Iss. 4, pp. 101675-101675
Open Access | Times Cited: 11
Development of morpholine ring-bearing halogenated α,β-unsaturated ketones as selective monoamine oxidase-B inhibitors
Jiseong Lee, Saranya Kattil Parmbil, Nagendar Kumar Pandit, et al.
Applied Biological Chemistry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top